SEC Form 3 · accession 0001209191-16-156103
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Davidson
Officer — Chief Medical Officer
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.35 | holding | — | — | — | — | Aug 31, 2026 | Common Stock | 30,000 | — | D |
Explanation of responses
- F1The shares underlying the option shall vest and become exercisable as to 25% on September 1, 2017; the balance of the shares underlying the option shall vest and become exercisable in 12 successive equal quarterly installments, in each case so long as the Reporting Person provides continuous service to the Issuer on each such date.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney